Why The U.S. Remains The Most Expensive Market For 'Biologic' Drugs In The World

  • 📰 NPR
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

In Europe, some of the world's costliest medicines are up to 80 percent cheaper than in the U.S. because drugmakers there must compete with biosimilars, or cheaper copies of biologic drugs.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 96. in FR
 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

Name brands are currently the only ones that work. Generics are virtually worthless. As useful as a screen door in a submarine. Bio similars might be worthwhile, we will see through time and testing, but for sure generics are the most costly because your paying for cut, and bunk.

They were able to “compel” drugmakers because governments in Europe have purchasing power from SinglePayer healthCARE systems. We want SenSanders MedicareForAllBill MedicareForAll us the future.

US refuses to follow the EU model; Trump often whines that EU needs to pay US pricing - EU Gov'ts have compelled drugmakers to lower prices & opened markets for 50 biosimilars, cheaper copies of injected drugs often derived from living organisms; 6 in US

Because our government often functions like a terrible VC. Simply ask MazzucatoM - great perspective on this

Democrats and Republicans taking bribes, that's why.

Thank God for rich Americans subsidizing these cheap drugs due the cheap gray market.

Because our government is told what laws to pass and ones to change by corporations. Big ones. And ultra wealthy individuals.

France Dernières Nouvelles, France Actualités